Gurnee, IL, United States of America

Jimmy D Page


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jimmy D. Page

Introduction

Jimmy D. Page is a notable inventor based in Gurnee, Illinois. He has made significant contributions to the field of medical technology, particularly in the monitoring of blood levels of antiplatelet compounds. His work has implications for patients undergoing treatment with these compounds, enhancing the safety and effectiveness of their therapies.

Latest Patents

Jimmy D. Page holds a patent for a method and reagent for monitoring blood levels of antiplatelet compounds. This innovative method allows for the determination of the amount of an antiplatelet compound in a subject's blood. It involves calculating the ACT number of the blood containing a reagent that immunoreacts with the antiplatelet compound and comparing this figure to a standardized concentration. Notably, this method can be applied to subjects concurrently treated with heparin without the need for additional heparin in the blood sample. The invention also includes reagents that immunoreact with antiplatelet compounds and kits comprising these immunoreactive reagents. He has 1 patent to his name.

Career Highlights

Jimmy D. Page has worked with G.D. Searle & Company, where he has been able to apply his innovative ideas in a practical setting. His contributions have been instrumental in advancing medical technology and improving patient care.

Collaborations

Throughout his career, Jimmy has collaborated with notable colleagues such as Larry P. Feigen and Christopher P. Carron. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Jimmy D. Page's innovative work in the field of medical technology exemplifies the importance of invention in improving healthcare outcomes. His patent for monitoring blood levels of antiplatelet compounds showcases his commitment to enhancing patient safety and treatment efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…